Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-Cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-1935
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Bortezomib Prevents Development of Cytarabine Resistance in a Mantle Cell Lymphoma in Vitro Model

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

CD40L Mediated Alternative NFκB-signaling Induces Resistance to BCR-inhibitors in Patients With Mantle Cell Lymphoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Pyridinium Fullerene Derivative Inhibits Cell Growth by Suppression of WNT Signaling in Virus-Infected Non-Hodgkin's B-Cell Lymphoma Cell.

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Actin-Mediated Feedback Loops in B-Cell Receptor Signaling

Immunological Reviews
AllergyImmunology
2013English

Lysophosphatidic Acid Receptor 5 Inhibits B Cell Antigen Receptor Signaling and Antibody Response

Journal of Immunology
AllergyImmunology
2014English

Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma

Nature
Multidisciplinary
2010English

Terminating B Cell Receptor Signaling

Oncotarget
Oncology
2017English

Copanlisib and Volasertib Overcome Ibrutinib-Venetoclax Resistance via Targeting Pi3k-Akt Signaling and G2/M Cell Cycle Transition in Mantle Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy